Health and Healthcare

Merck : MRK

All Merck Articles

1088 Articles

Chris Lange | Jan 28, 2019 at 10:10 AM EST

Short Interest Spikes in a Couple Major Pharma Stocks

The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jan 27, 2019 at 10:20 AM EST

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

24/7 Wall St. has put together a preview of those Dow Jones industrials scheduled to report their quarterly results this…

Chris Lange | Jan 24, 2019 at 9:50 AM EST

How the 30 Dow Stocks Are Doing in 2019

24/7 Wall St. has ranked these Dow Stocks on their performance thus far in 2019, as of Wednesday’s closing price.…

Jon C. Ogg | Jan 23, 2019 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amazon.com, Dell Technologies, IBM, International Paper, Merck, Pfizer,…

Chris Lange | Jan 11, 2019 at 9:50 AM EST

Major Pharma Sees Fading Short Interest

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 3, 2019 at 8:45 AM EST

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Merck shares were relatively unchanged early on Thursday after the firm announced that its blockbuster drug Keytruda reported a series…

Jon C. Ogg | Jan 2, 2019 at 7:55 AM EST

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

See why preliminary 2019 consensus-based forecasting has offered up a likely target of 28,000 on the Dow Jones industrial average…

Jon C. Ogg | Dec 31, 2018 at 2:20 PM EST

Meet the 2019 Dogs of the Dow

Investors love their dividends. So 24/7 Wall St. has tracked the Dogs of the Dow strategy for years now.

Chris Lange | Dec 27, 2018 at 10:00 AM EST

Short Sellers Hike Bets in Major Pharma Stocks

The December 14 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Dec 12, 2018 at 9:50 AM EST

Major Pharma Stocks See a Surge in Short Interest

The November 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Dec 8, 2018 at 7:20 AM EST

Major Health Care Catalysts Coming by the End of 2018

24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies…

Chris Lange | Nov 28, 2018 at 9:00 AM EST

Short Sellers Hike Their Bets in Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Nov 12, 2018 at 10:10 AM EST

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Nov 12, 2018 at 6:50 AM EST

The 6 Most Shorted NYSE Stocks

Judging by the most shorted stocks traded on the New York Stock Exchange between the October 15 and October 31…

Paul Ausick | Nov 3, 2018 at 8:04 AM EDT

Merck Takes Over as Dow’s Top-Performing Dow Stock

Drugmaker Merck wrestled away from Apple the top ranking last week as the best performing stock among the Dow 30.

1 … 18 19 20 21 22 … 73

Merck : MRK

All Merck Articles

Short Interest Spikes in a Couple Major Pharma Stocks

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

How the 30 Dow Stocks Are Doing in 2019

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Major Pharma Sees Fading Short Interest

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

Meet the 2019 Dogs of the Dow

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharma Stocks See a Surge in Short Interest

Major Health Care Catalysts Coming by the End of 2018

Short Sellers Hike Their Bets in Major Pharma Stocks

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The 6 Most Shorted NYSE Stocks

Merck Takes Over as Dow’s Top-Performing Dow Stock

‘Stop Being a Wimp and Be the Woman You Were Born to Be’: Suze Orman to a Debt-Free 38-Year-Old Paralyzed by AI Fears

Looking Beyond Nvidia? This Mid-Cap ETF Could Benefit from AI’s Next Growth Phase

The $850 Social Security Decision You Need to Make Carefully

'Stop Being a Wimp and Be the Woman You Were Born to Be': Suze Orman to a Debt-Free 38-Year-Old Paralyzed by AI Fears

The $850 Social Security Decision You Need to Make Carefully

‘Stop Being a Wimp and Be the Woman You Were Born to Be’: Suze Orman to a Debt-Free 38-Year-Old Paralyzed by AI Fears

Looking Beyond Nvidia? This Mid-Cap ETF Could Benefit from AI’s Next Growth Phase

Merck : MRK

All Merck Articles

Short Interest Spikes in a Couple Major Pharma Stocks

Apple, Boeing, Microsoft and More Dow Earnings Coming This Week

How the 30 Dow Stocks Are Doing in 2019

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Major Pharma Sees Fading Short Interest

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

Meet the 2019 Dogs of the Dow

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharma Stocks See a Surge in Short Interest

Major Health Care Catalysts Coming by the End of 2018

Short Sellers Hike Their Bets in Major Pharma Stocks

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The 6 Most Shorted NYSE Stocks

Merck Takes Over as Dow’s Top-Performing Dow Stock

‘Stop Being a Wimp and Be the Woman You Were Born to Be’: Suze Orman to a Debt-Free 38-Year-Old Paralyzed by AI Fears

Looking Beyond Nvidia? This Mid-Cap ETF Could Benefit from AI’s Next Growth Phase

The $850 Social Security Decision You Need to Make Carefully

Featured Reads

'Stop Being a Wimp and Be the Woman You Were Born to Be': Suze Orman to a Debt-Free 38-Year-Old Paralyzed by AI Fears

The $850 Social Security Decision You Need to Make Carefully